Organotin Complexes—Candidates for Antitumor Agents: Toxicity vs. Pharmaceutical Activity-Reference-Cited by-同舟云学术

Organotin Complexes—Candidates for Antitumor Agents: Toxicity vs. Pharmaceutical Activity

Published:2025-03 Issue:1 Volume:19 Page:1-20
ISSN:1990-7508
Container-title:Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
language:en
Short-container-title:Biochem. Moscow Suppl. Ser. B

Author:

Dodokhova M. A.,Kotieva I. M.,Alkhusein-Kulyaginova M. S.,Kotieva V. M.,Kotieva E. M.,Berseneva D. A.,Shpakovsky D. B.,Silin N. S.,Gulyan M. V.,Milaeva E. R.

Publisher

Pleiades Publishing Ltd

Link

https://link.springer.com/content/pdf/10.1134/S1990750824600791.pdf

Reference63 articles.

1. Dodokhova, M.A., Safronenko, A.V., Kotieva, I.M., Sukhorukova, N.V., Gantsgorn, E.V., Alkhusein-Kulyaginova, M.S., Komarova, E.F., Shpakovskii, D.B., and Milaeva, E.R., Estimation of pharmacotherapeutic potential of organotin compounds in vivo, Biofarm. Zh., 2021, vol. 13, pp. 30–34. https://doi.org/10.30906/2073-8099-2021-13-3-11-15

2. Banti, C.N., Hadjikakou, S.K., Sismanoglu, T., and Hadjiliadis, N., Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives, J. Inorg. Biochem., 2019, vol. 194, pp. 114–152. https://doi.org/10.1016/j.jinorgbio.2019.02.003

3. Devi, J., Boora, A., Rani, M., and Arora, T., Recent advancements in organotin(IV) complexes as potent cytotoxic agents, Anticancer Agents Med. Chem., 2023, vol. 23, pp. 164–191. https://doi.org/10.2174/1871520622666220520095549

4. Dodokhova, M.A., Safronenko, A.V., Kotieva, I.M., Alkhuseyn-Kulyaginova, M.S., Shpakovsky, D.B., and Milaeva, E.R., Impact of organotin compounds on the growth of epidermoid Lewis carcinoma, Res. Results Pharmacol., 2021, vol. 7, pp. 81–88. https://doi.org/10.3897/rrpharmacology.7.71455

5. Dodokhova, M.A., Safronenko, A.V., Kotieva, I.M., Alkhuseyn-Kulyaginova, M.S., Shpakovsky, D.B., and Milaeva, E.R., Evaluation of the pharmacological activity of hybrid organotin compounds in a B16 melanoma model in the classical and metronomic administration modes, Res. Results Pharmacol., 2022, vol. 8, pp. 85–93. https://doi.org/10.3897/rrpharmacology.8.76363